Related Experiment Video
Updated: May 23, 2026
DNA Vector-based RNA Interference to Study Gene Function in Cancer
Published on: June 4, 2012
[Anti-tumor effect of adenovirus-mediated Bcl-XL shRNA in vitro]
Yu-ping Zhu1, De-chuan Li, Hai-yang Feng
1Department of Colorectal Surgery, Zhejiang Cancer Hospital, Hangzhou 310022, China.
Objective:
To investigate the anti-tumor effect of adenovirus-mediated Bcl-XL shRNA on colon cancer cells in vitro.
Methods:
A recombinant Bcl-xl adenovirus was constructed, amplified, and purified. The effect on mRNA expression of Bcl-XL was assessed by RT-PCR, and the effect on apoptosis-induction of colon cancer(Lovo cell line) in vitro was assessed by MTT assay and cell clonogenic assay.
Results:
RT-PCR showed that Ad/Bcl-XL shRNA significantly down-regulated the mRNA expression of Bcl-XL in Lovo cells. Ad/Bcl-XL shRNA suppressed the proliferation of Lovo cells in a dose-dependent as well as a time-dependent manner compared with Ad/GFP (P<0.05). Treatment with Ad/Bcl-XL shRNA dramatically suppressed the colony formation of Lovo cells in a dose-dependent manner (P<0.05). Ad/Bcl-XL shRNA showed no effect on normal human fibroblast.
Conclusion:
Ad/Bcl-XL shRNA exhibits cytotoxic effect on Lovo cells and may have the potential value in the treatment of colon cancer.
Insights
Adenovirus-mediated Bcl-XL shRNA effectively reduced colon cancer cell proliferation and colony formation in vitro. This targeted therapy shows potential for colon cancer treatment by inducing cytotoxicity in cancer cells.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
Context:
- Colon cancer is a leading cause of cancer-related mortality worldwide.
- Targeting anti-apoptotic proteins like Bcl-XL is a promising strategy for cancer therapy.
- Gene silencing using short hairpin RNA (shRNA) offers a precise method for gene function investigation.
Purpose:
- To evaluate the anti-tumor efficacy of adenovirus-mediated Bcl-XL shRNA in colon cancer cells.
- To assess the impact of Bcl-XL gene silencing on colon cancer cell viability and proliferation.
- To determine the specificity of Ad/Bcl-XL shRNA on colon cancer cells versus normal fibroblasts.
Summary:
- A recombinant adenovirus carrying Bcl-XL shRNA (Ad/Bcl-XL shRNA) was constructed and validated.
- Ad/Bcl-XL shRNA significantly downregulated Bcl-XL mRNA expression in Lovo colon cancer cells.
- MTT and cell clonogenic assays demonstrated that Ad/Bcl-XL shRNA suppressed Lovo cell proliferation and colony formation in a dose- and time-dependent manner.
- Importantly, Ad/Bcl-XL shRNA did not affect the viability of normal human fibroblasts, indicating specificity.
Impact:
- Ad/Bcl-XL shRNA demonstrates significant cytotoxic effects on colon cancer cells.
- This study highlights the potential of Bcl-XL targeted gene therapy for colon cancer treatment.
- Further research may explore the in vivo efficacy and therapeutic applications of this approach.
More Related Videos
04:29Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
11:06Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018